Seelos Therapeutics Announces Data Demonstrating Statistically Significant Downregulation of mRNA and Reduction of Alpha Synuclein in an In Vitro Gene Therapy Study of SLS-004 Utilizing CRISPR-dCa...
- A Single Dose of SLS-004 Produced 19% Downregulation of mRNA and ~40% Reduction of Alpha-Synuclein Compared to the Control Group- These Results ...
New York United States Mike Moyer Anthony Marciano Exchange Commission Prnewswire Seelos Therapeutics Inc
Source: businessinsider.com